Orthobiologics

BIOINCYTE is a next-generation autologous fibrin and platelet system that converts traditional PRP to platelet rich fibrin matrix formulations....

DiscGenics announced positive two-year clinical data from its study of discogenic progenitor cell therapy in the treatment of degenerative disc...

OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgery....

Orthofix Medical announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite™ cellular...

The data supports development of autologous and allogeneic therapeutics for bone defects and orthopedic conditions....

XCELL PC is designed to offer easier use and reduced processing time compared to earlier generation blood and plasma filters...

Biocomposites has added Mexico to its list of countries where STIMULAN is cleared as an antibiotic carrier for use in...

DirectCell includes a synthetic bone graft and novel instrumentation engineered to harvest high concentrations of patient stem cells....

The STRUCTURE trial is evaluating Fibrin-PTH bone graft in transforaminal lumbar interbody fusion procedures....

HippoFi (formerly ORHub) launched PURbridge™ active bioglass, an expansion of the company's Regenerative Therapeutics offerings which target the spine market. The...